1. Influence of Self-MHC Class I Recognition on the Dynamics of NK Cell Responses to Cytomegalovirus Infection.
- Author
-
Potempa, Marc, Aguilar, Oscar A, Gonzalez-Hinojosa, Maria DR, Tenvooren, Iliana, Marquez, Diana M, Spitzer, Matthew H, and Lanier, Lewis L
- Subjects
Vaccine Related ,Infectious Diseases ,Biodefense ,Emerging Infectious Diseases ,Prevention ,2.1 Biological and endogenous factors ,Aetiology ,Animals ,Cytomegalovirus Infections ,Killer Cells ,Natural ,Mice ,Mice ,Inbred C57BL ,Muromegalovirus ,NK Cell Lectin-Like Receptor Subfamily A ,Immunology - Abstract
Although interactions between inhibitory Ly49 receptors and their self-MHC class I ligands in C57BL/6 mice are known to limit NK cell proliferation during mouse CMV (MCMV) infection, we created a 36-marker mass cytometry (CyTOF) panel to investigate how these inhibitory receptors impact the NK cell response to MCMV in other phenotypically measurable ways. More than two thirds of licensed NK cells (i.e., those expressing Ly49C, Ly49I, or both) in uninfected mice had already differentiated into NK cells with phenotypes indicative of Ag encounter (KLRG1+Ly6C-) or memory-like status (KLRG1+Ly6C+). These pre-existing KLRG1+Ly6C+ NK cells resembled known Ag-specific memory NK cell populations in being less responsive to IL-18 and IFN-α stimulation in vitro and by selecting for NK cell clones with elevated expression of a Ly49 receptor. During MCMV infection, the significant differences between licensed and unlicensed (Ly49C-Ly49I-) NK cells disappeared within both CMV-specific (Ly49H+) and nonspecific (Ly49H-) responses. This lack of heterogeneity carried into the memory phase, with only a difference in CD16 expression manifesting between licensed and unlicensed MCMV-specific memory NK cell populations. Our results suggest that restricting proliferation is the predominant effect licensing has on the NK cell population during MCMV infection, but the inhibitory Ly49-MHC interactions that take place ahead of infection contribute to their limited expansion by shrinking the pool of licensed NK cells capable of robustly responding to new challenges.
- Published
- 2022